Solid-phase combinatorial approach for the optimization of soluble epoxide hydrolase inhibitors

Sung Hee Hwang; Christophe Morisseau; Zung Do; Bruce D. Hammock

doi:10.1016/j.bmcl.2006.08.078

Solid-phase combinatorial approach for the optimization of soluble epoxide hydrolase inhibitors

Sung Hee Hwang, Christophe Morisseau, Zung Do, Bruce D. Hammock

Entomology

Research output: Contribution to journal › Article

26 Scopus citations

Abstract

A 192-member library of N,N′-disubstituted urea inhibitors was synthesized by a solid-phase method. The ureas were tested for their inhibitory activities against recombinant human soluble epoxide hydrolase. Simple carbocyclic or para/meta-substituted phenyl groups showed inhibition potencies that were equal to or greater than adamantane-based sEH inhibitors, while the presence of bulky or ionizable groups close to the urea group dramatically decreased their activities.

Original language	English (US)
Pages (from-to)	5773-5777
Number of pages	5
Journal	Bioorganic and Medicinal Chemistry Letters
Volume	16
Issue number	22
DOIs	https://doi.org/10.1016/j.bmcl.2006.08.078
State	Published - Nov 15 2006

Fingerprint

Keywords

Anti-inflammation
Hypertension
Soluble epoxide hydrolase
Urea

ASJC Scopus subject areas

Biochemistry
Molecular Biology
Organic Chemistry
Drug Discovery
Pharmaceutical Science

Cite this

Hwang, S. H., Morisseau, C., Do, Z., & Hammock, B. D. (2006). Solid-phase combinatorial approach for the optimization of soluble epoxide hydrolase inhibitors. Bioorganic and Medicinal Chemistry Letters, 16(22), 5773-5777. https://doi.org/10.1016/j.bmcl.2006.08.078

@article{5e905edd5c784f94b6fd6204c4b13cfd,

title = "Solid-phase combinatorial approach for the optimization of soluble epoxide hydrolase inhibitors",

abstract = "A 192-member library of N,N′-disubstituted urea inhibitors was synthesized by a solid-phase method. The ureas were tested for their inhibitory activities against recombinant human soluble epoxide hydrolase. Simple carbocyclic or para/meta-substituted phenyl groups showed inhibition potencies that were equal to or greater than adamantane-based sEH inhibitors, while the presence of bulky or ionizable groups close to the urea group dramatically decreased their activities.",

keywords = "Anti-inflammation, Hypertension, Soluble epoxide hydrolase, Urea",

author = "Hwang, {Sung Hee} and Christophe Morisseau and Zung Do and Hammock, {Bruce D.}",

year = "2006",

month = nov

day = "15",

doi = "10.1016/j.bmcl.2006.08.078",

language = "English (US)",

volume = "16",

pages = "5773--5777",

journal = "Bioorganic and Medicinal Chemistry Letters",

issn = "0960-894X",

publisher = "Elsevier Limited",

number = "22",

}

TY - JOUR

T1 - Solid-phase combinatorial approach for the optimization of soluble epoxide hydrolase inhibitors

AU - Hwang, Sung Hee

AU - Morisseau, Christophe

AU - Do, Zung

AU - Hammock, Bruce D.

PY - 2006/11/15

Y1 - 2006/11/15

N2 - A 192-member library of N,N′-disubstituted urea inhibitors was synthesized by a solid-phase method. The ureas were tested for their inhibitory activities against recombinant human soluble epoxide hydrolase. Simple carbocyclic or para/meta-substituted phenyl groups showed inhibition potencies that were equal to or greater than adamantane-based sEH inhibitors, while the presence of bulky or ionizable groups close to the urea group dramatically decreased their activities.

AB - A 192-member library of N,N′-disubstituted urea inhibitors was synthesized by a solid-phase method. The ureas were tested for their inhibitory activities against recombinant human soluble epoxide hydrolase. Simple carbocyclic or para/meta-substituted phenyl groups showed inhibition potencies that were equal to or greater than adamantane-based sEH inhibitors, while the presence of bulky or ionizable groups close to the urea group dramatically decreased their activities.

KW - Anti-inflammation

KW - Hypertension

KW - Soluble epoxide hydrolase

KW - Urea

UR - http://www.scopus.com/inward/record.url?scp=33749251458&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33749251458&partnerID=8YFLogxK

U2 - 10.1016/j.bmcl.2006.08.078

DO - 10.1016/j.bmcl.2006.08.078

M3 - Article

C2 - 16949285

AN - SCOPUS:33749251458

VL - 16

SP - 5773

EP - 5777

JO - Bioorganic and Medicinal Chemistry Letters

JF - Bioorganic and Medicinal Chemistry Letters

SN - 0960-894X

IS - 22

ER -

Access to Document

10.1016/j.bmcl.2006.08.078